Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management

Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the most recently defined inflammatory demyelinating disease of the central nervous system (CNS). Over the last decade, several studies have helped delineate the characteristic clinical-MRI phenotypes of the disease, al...

Full description

Bibliographic Details
Main Authors: Elia Sechi, Laura Cacciaguerra, John J. Chen, Sara Mariotto, Giulia Fadda, Alessandro Dinoto, A. Sebastian Lopez-Chiriboga, Sean J. Pittock, Eoin P. Flanagan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Neurology
Subjects:
MOG
NMOSD
neuromyelitis optica
multiple sclerosis
demyelinating diseases
false positive
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.885218/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2022.885218/full

Similar Items